-
Home
-
anti-human Ig lambda mouse monoclonal, 48.0, supernatant
Product description
Host |
mouse |
Antibody Type |
monoclonal |
Isotype |
IgG1 |
Clone |
48 |
Immunogen |
Isolated from Bence Jones lambda proteins |
Purification |
hybridoma cell culture supernatant |
Conjugate |
unconjugated |
Formulation |
contains 0.09% sodium azide |
Storage |
short term at 2-8°C; long term storage in aliquots at -20°C; avoid freeze/ thaw cycles |
No. of experiments |
≤ 200 (IHC, 50 µl/slide) |
Note |
centrifuge prior to opening |
Intended use |
Research use only |
Tested species reactivity |
human |
Applications
Tested applications |
Tested dilutions
|
ELISA |
assay dependent |
Immunocytochemistry (ICC)/ Immunofluorescence (IF) |
assay dependent |
Immunohistochemistry (IHC) - frozen |
1:5 – 1:10 |
Immunohistochemistry (IHC) - paraffin |
1:5 – 1:10 (microwave treatment recommended) |
Background
Details
Suitable for characterization of malignant B-cell proliferations. All but acute lymphocytic leukemias share either surface or intra-cytoplasmic Ig with an isotypic restriction suggesting a monoclonal nature of the cell population. Most of the chronic lymphocytic leukemias, non Hodgkin lymphomas and Burkitt’s lymphoma bear surface IgM, whereas plasmocytes from Waldenstöm’s disease bear intracytoplasmic IgM. The other isotypes are found less frequently; multiple myelomas are usually of the IgG or IgA type. Also suitable for the characterization of plasma cells in intestinal inflammatory conditions, e.g. for the classification of intestinal bowel disease and allergic conditions.
In the latter case a specific increase in the number of IgE plasma cells can be demonstrated.
In ELISA the antibody reacts with lambda light chains of secreted immunoglobulins and with bound Ig on the surface of B lymphocytes.
Positive control: tonsil.
Reference
There are currently no references for this product.
Material safety data sheet
Please complete the form below to request a material safety data sheet
Product Request
This website uses cookies. By continuing to browse the site you are agreeing to our use of cookies.